Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

48 trials with published results (34%)

Research Maturity

100 completed trials (71% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

6.4%

9 terminated out of 140 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

29%

41 trials in Phase 3/4

Results Transparency

48%

48 of 100 completed with results

Key Signals

48 with results92% success

Data Visualizations

Phase Distribution

98Total
Not Applicable (21)
Early P 1 (1)
P 1 (11)
P 2 (24)
P 3 (26)
P 4 (15)

Trial Status

Completed100
Recruiting12
Terminated9
Unknown9
Not Yet Recruiting4
Enrolling By Invitation2

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 100 completed trials

Clinical Trials (140)

Showing 20 of 20 trials
NCT05393492Not ApplicableRecruiting

Regulating Emotions and Behaviors After Brain Injury

NCT07622147Not ApplicableNot Yet Recruiting

Immune-Mitochondrial Correction in Military Recruits

NCT07027475Recruiting

Acute Treatment and Long-term Assessment of Adult Infectious Meningitis

NCT07062445RecruitingPrimary

Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis

NCT01593514Phase 4CompletedPrimary

Understanding the Immune Response to Two Different Meningitis Vaccines

NCT04664569RecruitingPrimary

National Bacterial Meningitis Study in Children and Newborns

NCT06995430Phase 3CompletedPrimary

A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)

NCT06592586Phase 2Active Not Recruiting

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

NCT05093829Phase 3CompletedPrimary

Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine

NCT06820060Active Not RecruitingPrimary

Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus

NCT07432113Not ApplicableNot Yet RecruitingPrimary

Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.

NCT07358910Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

NCT07332234RecruitingPrimary

Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies

NCT05496673Not ApplicableRecruitingPrimary

Meningitis: Burden, Causes, Screening and Prevention in Rural Northern Uganda

NCT07320599Not Yet RecruitingPrimary

Neuroendoscopic Surgery With Ommaya Reservoir Implantation vs. Burr Hole Drainage for Infantile Postmeningitis Subdural Lesions: Superior Efficacy, Critical Impact of Surgical Timing, and Pathogenic Bacteria as Risk Factors for Progression

NCT07186881Enrolling By Invitation

Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis

NCT06584864Not ApplicableRecruitingPrimary

Bedside Ultrasound on the Effectiveness of Lumbar Puncture in Children.

NCT07052656Completed

Risk Factors and Outcomes in Patients Treated in Neurocritical Care

NCT07044037Completed

Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)

NCT04190303CompletedPrimary

BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally

Scroll to load more

Research Network

Activity Timeline